Skip to main content

CH-FIT trial

Interested in our Congenital Heart Fitness Intervention Trial?

Find out more

HRI is an internationally recognised medical research institute, with global collaborations.

It is a unique time to join HRI. The next few years have the potential to be transformative, with developments such as the $150 million Cardiovascular Disease Research Capacity Building Program backed by the NSW government in 2018, and HRI’s strong fundraising capabilities, which provide a reliable and independent source of long-term funding.

Our success comes down to our people. From our scientists and researchers, to our operations and fundraising staff – they all play key roles in ensuring HRI’s place as a world-leading medical research institute.

Positions available

Postdoctoral Researcher - Atherosclerosis and Vascular Remodelling

HRI is seeking a postdoctoral scientist to contribute to innovative and collaborative research programs with a focus on cardiovascular genetic approaches to better understand the biology of the vasculature. This research is part of a partnership between HRI, University of Sydney's Charles Perkins Centre and the Centre for Cardiovascular Science, Queen’s Medical Research Institute at the University of Edinburgh. The scientist will investigate new molecular targets to be developed into novel treatment methods to prevent plaque rupture. Furthermore, there is a unique opportunity for the candidate to travel to the University of Edinburgh for single cell RNA-sequencing component of this project. Find out more and apply.

Postdoctoral Researcher - Microvascular Physiology

An exciting opportunity exists to carry out two years of fully funded post-doctoral research investigating the impact of septic shock on microvascular function. This position is split across the laboratories of Dr Chris Stanley at the Heart Research Institute (HRI), University of Sydney, Australia and Dr’s Adam Greenstein and Harry Pritchard’s small artery group at the University of Manchester, UK. The successful candidate will spend a year working in Sydney, Australia and then a year in Manchester, UK. The appointed person will work with microvascular arteries taken from models of septic shock to understand how disease pathology changes membrane potential and calcium signalling. Find out more and apply.

Contact us

Interested in our Congenital Heart…

Find out more